Shares in several European and Asian makers of generic medicines fell after President Trump said the U.S. would place tariffs ...

Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee ...

U.S. President Donald Trump has set his sights on generic drug imports into the U.S. amid the latest bout of trade tensions ...

Arizona Attorney General Kris Mayes announced a nearly $30 million settlement with pharmaceutical company Glenmark over ...

Private equity firm’s first majority bet in Indian pharma aims to build a branded generics powerhouse as Novartis India ...

Generic drug manufacturers will have two years to move production to the U.S. or face a 100% import duty from August 2028, President Donald Trump said in a ...

A federal appeals court has upheld the Nuclear Regulatory Commission’s (NRC’s) use of a generic environmental analysis for nuclear plant license renewals, ...

For seniors and other Medicare beneficiaries enrolled in stand-alone Part D plans, the change means insurers will set their ...

As the Iran war restarts and expands, Trump and Republicans sink in new polls ahead of the midterm elections.

A Medicare Part D subsidy called the Premium Stabilization Demonstration is coming to an end this year. In a recent X ...

Sinesipho Dambile had arrived at the Commonwealth Games as the fastest entrant in the men’s 200m, and before anyone suggests it’s a watered-down event, his time of 19.74 in a Diamond League meeting in ...

FORT LAUDERDALE, FL / / July 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, is plea ...